NRG-LU002 Results and Impact with Dr. Iyengar

Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs...

13 Elo 17min

Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts...

30 Heinä 28min

For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.

15 Heinä 38min

This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus S...

23 Kesä 49min

In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.

30 Touko 29min

Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.

29 Touko 18min

The NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and overcoming obstacles in radi...

27 Huhti 31min

Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.

10 Huhti 17min